Table 4 Biochemical parameters for triple therapies—DPP4I study, Anuradhapura 2017
Investigation | OOH group (n = 03) | DPP4I group (n = 56) | Estimated difference of means (95% CI) | ||
|---|---|---|---|---|---|
Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | ||
HbA1C (%) | 7.8 (7–8) | 7.5 (0.6) | 8.5 (7–10) | 8.7 (1.8) | 1.2 (−0.9 to 3.3) |
Pancreatic amylase (U/L) | 80 (41–80) | 67 (22.5) | 36.5 (31–52) | 45.3 (26.2) | − 21.7 (−52.6 to 9.3) |
Serum lipase (U/L) | 45 (41–46) | 44 (2.7) | 51 (40–71) | 67.2 (69.1) | 23.2 (−57.4 to 103.8) |
AST (U/L) | 27 (14–55) | 32 (21) | 26 (19–34) | 28.9 (16.6) | − 3.1 (−23.0 to 16.8) |
ALT (U/L) | 16 (12–43) | 23.7 (16.9) | 24 (16–37) | 30.8 (20.8) | 7.1 (−17.4 to 31.6) |